ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619321 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619321; 2) Community: the network communities that were significantly associated with the response to NSC 619321; 3) Molecule: the relationships between components within communities and NSC 619321; 4) MDR: the compounds that were significantly associated with the NSC 619321.

NSC Compound Enrichment Correlation
NSC 665514 Null 0.0285477013888569 -0.14632673
NSC 674268 Null 0.0285477013888569 0.19247125
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0285477013888569 -0.25081901
NSC 681633 Camptothecin Derivative 0.0285477013888569 0.27115255
NSC 681641 Camptothecin Derivative 0.0285477013888569 0.25193456
NSC 683517 8H-Thieno[2,3-b]pyrrolizinium, 3-(4-bromophenyl)-4-methyl- 8-(1-pyrrolidinyl)-, iodide 0.0285477013888569 0.24714763
NSC 697730 Null 0.0285477013888569 -0.29208571
NSC 715843 Null 0.0285477013888569 -0.23846151
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0285477013888569 0.20673845
NSC 728133 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,5-dichlorobenzene 0.0285477013888569 0.017057461
Total:44  Current:29    [First] [Prev] [Next] [Last]